Taub Rebecca sold MDGL
January 9, 2026 · Form 4 insider transaction
Taub Rebecca sold 1,135 shares of Madrigal Pharmaceuticals, Inc. at $526.95 per share, a transaction worth $598.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,135
Price
$526.95
Total value
$598.1K
InsiderTaub Rebecca
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 9, 2026
Filing dateJanuary 13, 2026
Shares owned after458,858
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $526.63 to $527.58, inclusive.